Trodelvy Boosts PFS in First-Line Metastatic TNBC Patients
May 23, 2025
Second Positive Phase 3 Trial in First-line Metastatic TNBC Where Trodelvy Has Demonstrated a Clinically Meaningful Benefit Versus Standard of Care Chemotherapy Gilead Sciences, Inc.